Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06621667

Diaphragmatic Myofascial Release for Hyperkyphotic Subjects

kyphotic subjects have respiratory disturbances due to weakening of the diaphragm, responsible for inhalation, which lead to abnormalities in respiratory mechanics and abnormal gas exchange, leading to respiratory complications. Myofascial release of the diaphragm is an intervention intended to indirectly stretch the diaphragm muscle fibers to reduce muscle tension, normalize fiber length, and promote the efficiency of muscle contraction. Although diaphragm myofascial release has been used in clinical practice, to the best of the authors' knowledge, the current study is the first research investigating the effect of diaphragmatic myofascial release on lung function, chest mobility and kyphotic curve in hyperkyphotic subjects.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The participant's age ranged from 20 to 40 years.
  • kyphosis angle 40-50◦
  • reporting pain on palpation of the diaphragm

Exclusion criteria

  • A history of respiratory diseases, heart disease, vascular disease, central nervous system disorder, psychiatric disorders, hypertension.
  • History of any trauma or fracture to the thoracic spine.
  • inflammatory diseases such as rheumatoid arthritis, musculoskeletal problem and neurological deficit
  • Restrictive respiratory disease, smokers.

Treatment and study plan

diaphragmatic myofascial release with traditional physical therapy exercises for hyperkyphosis

Other

diaphragmatic myofascial release

traditional physical therapy exercises for hyperkyphosis

Other

traditional physical therapy exercises for hyperkyphosis

Primary outcomes

  1. maximum voluntary ventilation

    Time frame: change from base line at 4 weeks.

    the maximum voluntary ventilation will be measured using spirometer

Secondary outcomes

  1. Chest expansion

    Time frame: change from base line at 4 weeks.

    the chest expansion will be measured using tap measurement

  2. kyphotic angle

    Time frame: change from base line at 4 weeks.

    the kyphotic angle will be measured with flexicurve

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Response of Lung Function, Chest Mobility, and Kyphotic Curve to Diaphragmatic Myofascial Release in Hyperkyphotic Subjects: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 1, 2024
Registry last updated
Oct 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.